Rose Lab Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $7.19M

  • Investors
  • 8

Rose Lab General Information

Description

Developer of a nanosized filler designed to facilitate tissue restoration for facial plastic surgery. The company provides polymer-based restorative materials for living tissues and develops various medical technologies, such as polymer materials and cell therapy matrix development, which help to produce collagen in the body, enabling clients to improve skin aging.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd, 14th, 15th Floor, CS Tower, 209 Bongeunsa-ro
  • Gangnam-gu
  • Seoul, Nonhyeon 06109
  • South Korea
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Other Devices and Supplies
Corporate Office
  • 3rd, 14th, 15th Floor, CS Tower, 209 Bongeunsa-ro
  • Gangnam-gu
  • Seoul, Nonhyeon 06109
  • South Korea

Rose Lab Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rose Lab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 27-Aug-2025 $7.19M Completed Generating Revenue
4. Later Stage VC (Series A) 22-Sep-2023 Completed Generating Revenue
3. Later Stage VC (Series A) 15-Jun-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Mar-2021 Completed Generating Revenue
1. Seed Round 27-Aug-2020 Completed Startup
To view Rose Lab’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rose Lab Patents

Rose Lab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026177568-A1 Cosmetic composition for improving skin elasticity or reducing pore size comprising amphiphilic biocompatible polymer Pending 21-Feb-2025
WO-2026095730-A1 Composition for alleviating or treating vasodilatory or inflammatory skin diseases comprising amphiphilic biocompatible polymer Pending 01-Nov-2024
US-20260014295-A1 Composition for tissue repair comprising copolymer of hydrophilic biocompatible polymer and hydrophobic biocompatible polymer Pending 25-May-2022
WO-2023229187-A1 Composition for tissue repair comprising copolymer of hydrophilic biocompatible polymer and hydrophobic biocompatible polymer Inactive 25-May-2022
US-12508344-B2 Composition for restoration of tissue including biodegradable polymeric copolymer Active 13-Feb-2020 A61L27/18
To view Rose Lab’s complete patent history, request access »

Rose Lab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rose Lab Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Reverent Partners PE/Buyout Minority
Shinhan Capital Venture Capital Minority
GS Ventures (Korea) Corporate Venture Capital Minority
Tech Incubator Program for Startup Accelerator/Incubator Minority
Daedeok Venture Partners Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Rose Lab FAQs

  • When was Rose Lab founded?

    Rose Lab was founded in 2016.

  • Where is Rose Lab headquartered?

    Rose Lab is headquartered in Seoul, South Korea.

  • What is the size of Rose Lab?

    Rose Lab has 24 total employees.

  • What industry is Rose Lab in?

    Rose Lab’s primary industry is Biotechnology.

  • Is Rose Lab a private or public company?

    Rose Lab is a Private company.

  • What is the current valuation of Rose Lab?

    The current valuation of Rose Lab is .

  • What is Rose Lab’s current revenue?

    The current revenue for Rose Lab is .

  • How much funding has Rose Lab raised over time?

    Rose Lab has raised $7.19M.

  • Who are Rose Lab’s investors?

    Reverent Partners, Shinhan Capital, GS Ventures (Korea), Tech Incubator Program for Startup, and Daedeok Venture Partners are 5 of 8 investors who have invested in Rose Lab.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process